(talquetamab-tgvs)
This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
Last Updated: 07/29/2024
A literature search of MEDLINE®
1 | Data on File. Talquetamab. Investigational product preparation and administration instruction for subcutaneous administration of 2 mg/mL (3 mg) and 40 mg/mL (40 mg). Janssen Research and Development, LLC. TV-TEC-207195; version 5.0; 2024. |